Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
19 studies found for:    "Hypolipoproteinemia"
Show Display Options
RSS Create an RSS feed from your search for:
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration
Conditions: Lipid Metabolism, Inborn Errors;   Hyperlipidemias;   Metabolic Diseases;   Hypolipoproteinemia;   Hypolipoproteinemias;   Hypobetalipoproteinemias;   Metabolism, Inborn Errors;   Genetic Diseases, Inborn;   Infant, Newborn, Diseases;   Congenital Abnormalities;   Metabolic Disorder;   Hypercholesterolemia;   Dyslipidemias;   Lipid Metabolism Disorders
Interventions: Drug: mipomersen;   Drug: Placebo
2 Completed Exercise Versus Niacin in Patients With Coronary Artery Disease (CAD) and Low High-Density Lipoproteins (HDL)
Conditions: Coronary Disease;   Hypolipoproteinemia
Interventions: Behavioral: physical exercise;   Drug: niaspan (extended-release niacin);   Drug: niacin;   Other: control
3 Recruiting Evaluation of Lipoproteins
Conditions: Hyperlipidemia;   Hyperlipoproteinemia;   Hypolipoproteinemia
4 Completed High-Density Lipoprotein (HDL) Treatment Study
Conditions: Coronary Arteriosclerosis;   Hypoalphalipoproteinemias;   Genetic Diseases, Inborn
Intervention: Drug: Atorvastatin; Fenofibrate; Niacin
5 Recruiting Prevalence Assessment and Characterization of Psychological Disorders Associated With Hypobetalipoproteinemia
Condition: Hypobetalipoproteinemia
Intervention: Other: Hypobetalipoproteinemia diagnosis (LDL-C ≤ 50 mg/dL without hypolipidemic treatment)
6 Recruiting CER-001 Therapy as a Novel Approach to Treat Genetic Orphan Diseases
Condition: Familial Hypoalphalipoproteinemia
Interventions: Drug: CER-001;   Drug: Placebo
7 Recruiting Inherited Retinal Degenerative Disease Registry
Conditions: Eye Diseases Hereditary;   Retinal Disease;   Achromatopsia;   Bardet-Biedl Syndrome;   Bassen-Kornzweig Syndrome;   Batten Disease;   Best Disease;   Choroidal Dystrophy;   Choroideremia;   Cone Dystrophy;   Cone-Rod Dystrophy;   Congenital Stationary Night Blindness;   Enhanced S-Cone Syndrome;   Fundus Albipunctatus;   Goldmann-Favre Syndrome;   Gyrate Atrophy;   Juvenile Macular Degeneration;   Kearns-Sayre Syndrome;   Leber Congenital Amaurosis;   Refsum Syndrome;   Retinitis Pigmentosa;   Retinitis Punctata Albescens;   Retinoschisis;   Rod-Cone Dystrophy;   Rod Dystrophy;   Rod Monochromacy;   Stargardt Disease;   Usher Syndrome
8 Recruiting HYPOCHOL : A Genetically-based Strategy to Identify New Targets in Cholesterol Metabolism
Condition: Hypobetalipoproteinemia
Intervention: Genetic: hypobetalipoproteinemia genetic and genotypic screening
9 Completed Short-term Effect of Extended-release Niacin on Endothelial Function.
Condition: Hypoalphalipoproteinemia
Intervention: Drug: Niacin
10 Completed Effect of High Protein Diet on Adiponectin and Inflammation Among Overweight and Obese Children
Conditions: Body Mass Index Quantitative Trait Locus 5 Disorder;   Tangier Disease
Intervention: Other: nutrition intervention
11 Completed Effect of High Protein Diet on Cardiovascular Diseases Risk Factors Among Overweight and Obese Children
Conditions: Body Mass Index Quantitative Trait Locus 7 Disorder;   Tangier Disease
Intervention: Other: nutrition intervention
12 Active, not recruiting Mendelian Reverse Cholesterol Transport Study
Conditions: Cholesterol, HDL;   Lipid Metabolism, Inborn Errors;   Tangier Disease;   LCAT Deficiency;   Cholesteryl Ester Transfer Protein (CETP) Deficiency
Intervention: Drug: 3H-cholesterol bound to albumin
13 Completed High Protein Weight Loss Diet, High Sensitivity C-Reactive Protein and Cardiovascular Risks Among Obese Women
Conditions: Body Mass Index Quantitative Trait Locus 8 Disorder;   Tangier Disease
Intervention: Other: nutrition intervention
14 Completed Study of the Absorption of Vitamin E Water-soluble Form (Pegylated) in the Familial Hypocholesterolemia With Chylomicron Retention
Condition: Hypobetalipoproteinemias
Interventions: Drug: Tocofersolan;   Drug: tocopherol alpha;   Drug: Tocofersolan and tocopherol alpha
15 Completed
Has Results
Tomato Consumption and High Density Lipoprotein-cholesterol
Condition: Hypoalphalipoproteinemia
Interventions: Dietary Supplement: Tomato consumption;   Dietary Supplement: Cucumber consumption
16 Completed Mechanisms of Low Levels of Apolipoprotein B
Conditions: Cardiovascular Diseases;   Heart Diseases;   Hypobetalipoproteinemia
17 Completed Quantitative Genetic Analysis of Lipid Research Clinic Family Data
Conditions: Cardiovascular Diseases;   Heart Diseases;   Coronary Disease;   Tangier Disease;   Atherosclerosis
18 Completed Vitamin Replacement in Abetalipoproteinemia
Condition: Abetalipoproteinemia
19 Recruiting Lipoprotein Metabolism in Normal Volunteers and Patients With High Levels of Lipoproteins
Conditions: Abetalipoproteinemia;   Atherosclerosis;   Healthy;   Inborn Errors Lipid Metabolism

Indicates status has not been verified in more than two years